Mechanisms of Rapid Bactericidal and Anti-Biofilm Alpha-Mangostin In Vitro Activity against Staphylococcus aureus

Pol J Microbiol. 2023 Jun 14;72(2):199-208. doi: 10.33073/pjm-2023-021. eCollection 2023 Jun 1.

Abstract

Alpha-mangostin (α-mangostin) was discovered as a potent natural product against Gram-positive bacteria, whereas the underlying molecular mechanisms are still unclear. This study indicated that α-mangostin (at 4 × MIC) rapidly killed Staphylococcus aureus planktonic cells more effectively (at least 2-log10 CFU/ml) than daptomycin, vancomycin and linezolid at 1 and 3 h in the time-killing test. Interestingly, this study also found that a high concentration of α-mangostin (≥4×MIC) significantly reduced established biofilms of S. aureus. There were 58 single nucleotide polymorphisms (SNPs) in α-mangostin nonsensitive S. aureus isolates by whole-genome sequencing, of which 35 SNPs were located on both sides of the sarT gene and 10 SNPs in the sarT gene. A total of 147 proteins with a different abundance were determined by proteomics analysis, of which 91 proteins increased, whereas 56 proteins decreased. The abundance of regulatory proteins SarX and SarZ increased. In contrast, the abundance of SarT and IcaB was significantly reduced (they belonged to SarA family and ica system, associated with the biofilm formation of S. aureus). The abundance of cell membrane proteins VraF and DltC was augmented, but the abundance of cell membrane protein UgtP remarkably decreased. Propidium iodide and DiBaC4(3) staining assay revealed that the fluorescence intensities of DNA and the cell membrane were elevated in the α-mangostin treated S. aureus isolates. In conclusion, this study reveals that α-mangostin was effective against S. aureus planktonic cells by targeting cell membranes. The anti-biofilm effect of α-mangostin may be through inhibiting the function of SarT and IcaB.

Keywords: SarT; Staphylococcus aureus; alpha-mangostin; biofilm; cell membrane.

MeSH terms

  • Anti-Bacterial Agents / pharmacology
  • Humans
  • Membrane Proteins
  • Plankton
  • Staphylococcal Infections*
  • Staphylococcus aureus*
  • Vancomycin

Substances

  • mangostin
  • Anti-Bacterial Agents
  • Vancomycin
  • Membrane Proteins

Grants and funding

This work was supported by the following grants: National Natural Science Foundation of China (grants 82172283); Natural Science Foundation of Guangdong Province, China (No. 2020A1515111146, 2020A1515011049, 2020A1515010979); Shenzhen Key Medical Discipline Construction Fund (No.SZXK06162); the Science, Technology and Innovation Commission of Shenzhen Municipality basic research funds (JCYJ20180302144403714, JCYJ20180302144345028, JCYJ20180302144721183, JCYJ20190809110209389, JCYJ20220 530141810023 and JCYJ20220530142006015) and key funds (JCYJ20180508162403996); and the science funds of the Nanshan District Government (NS2021066, NS2021009, NS2021140).